I’m surprised the price is still so low after such a bullish announcement. Guessing the institutional traders/investors must still be getting adjusted to life back at the office after a decent break. These are the hard numbers that prove iTrack Advance is indeed a best in class treatment that will grow rapidly in sales and become a gold standard of treatment for Glaucoma. If they could get 65% growth even with everything that was going on towards the end of last year, well that’s a pretty amazing accomplishment. Very surprised that the market is still clearly asleep with this one.
Ann: USA Sales Update, page-31
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $56.06M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.8¢ | 24.0¢ | $61.84K | 254.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 353553 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 254871 | 2 |
View Market Depth
| Last trade - 15.54pm 30/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |